HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Janssen Selected Research

Vaccine Excipients

5/2022[ARN COVID-19 COMIRNATY Vaccine desensitization in a case of PEG Severe Immediate Hypersensitivity].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Janssen Research Topics

Disease

2Hypoxia (Hypoxemia)
09/2011 - 03/2010
1COVID-19
05/2022
1Immediate Hypersensitivity
05/2022
1Hypersensitivity (Allergy)
05/2022
1Acquired Immunodeficiency Syndrome (AIDS)
01/2019
1Infections
09/2012
1Hypercapnia
09/2011

Drug/Important Bio-Agent (IBA)

1VaccinesIBA
05/2022
1SolutionsIBA
05/2022
1BNT162 VaccineIBA
05/2022
1Vaccine ExcipientsIBA
05/2022
1Rifampin (Rifampicin)FDA LinkGeneric
09/2012
1Anti-Bacterial Agents (Antibiotics)IBA
09/2012
1Levofloxacin (Levaquin)FDA Link
09/2012
1Clostridium perfringens epsilon-toxinIBA
09/2011
1Digoxin (Digitek)FDA LinkGeneric
03/2010

Therapy/Procedure

1Contraindications
05/2022
1Therapeutics
01/2019
1Intravenous Infusions
03/2010